• About Us
    • Who We Are
    • Our History
    • Mission & Values
    • Our Leadership
    • Why Choose Jost
  • Products
    • Ammonium
    • Calcium
    • Copper
    • Iron
    • Magnesium
    • Manganese
    • Potassium
    • Sodium
    • Strontium
    • Zinc
    • Ultra Pure Minerals (Low Heavy Metals)
    • JOSTCOTE® Microencapsulated Products
    • New Products
    • Custom Products
  • Our Expertise
    • cGMP Manufacturing
    • Quality
    • Research & Development
    • Customer Service
  • Markets
    • Nutritional
    • Pharmaceutical / Biotech
    • Specialty
  • Media
    • News
    • Events
    • Videos
  • Technical Info
    • Documents
    • Links
  • Contact Us
    • Sales & Customer Service
    • Locations
  • Careers
Jost Chemical Co.
  • FAQ
  • Download Catalog
  • 314-428-4300
  • About Us
    • Who We Are
    • Our History
    • Mission & Values
    • Our Leadership
    • Why Choose Jost
  • Products
    • Ammonium
    • Calcium
    • Copper
    • Iron
    • Magnesium
    • Manganese
    • Potassium
    • Sodium
    • Strontium
    • Zinc
    • Ultra Pure Minerals (Low Heavy Metals)
    • JOSTCOTE® Microencapsulated Products
    • New Products
    • Custom Products
  • Our Expertise
    • cGMP Manufacturing
    • Quality
    • Research & Development
    • Customer Service
  • Markets
    • Nutritional
    • Pharmaceutical / Biotech
    • Specialty
  • Media
    • News
    • Events
    • Videos
  • Technical Info
    • Documents
    • Links
  • Contact Us
    • Sales & Customer Service
    • Locations
  • Careers
Home › Related Articles › Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes.
Nephrology Dialysis Transplantation. 2017 Mar

Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes.

Abstract:

BACKGROUND: Gitelman syndrome (GS) is a rare recessively inherited renal tubulopathy associated with renal potassium (K) and magnesium (Mg) loss. It requires lifelong K and Mg supplementation at high doses that are at best unpalatable and at worst, intolerable. In particular, gastrointestinal side effects often limit full therapeutic usage.

METHODS: We report here the analysis of a cohort of 28 adult patients with genetically proven GS who attend our specialist tubular disorders clinic, in whom we initiated the use of a modified-release Mg preparation (slow-release Mg lactate) and who were surveyed by questionnaire.

RESULTS: Twenty-five patients (89%) preferred the new treatment regimen. Of these 25, 17 (68%) regarded their symptom burden as improved and seven reported no worsening. Of the 25 who were not Mg-treatment naïve, 13 (59%) patients reported fewer side effects, 7 (32%) described them as the same and only 2 (9%) considered side effects to be worse. Five were able to increase their dose without ill-effect. Overall, biochemistry improved in 91% of the 23 patients switched from therapy with other preparations who chose to continue the modified-release Mg preparation. Eleven (48%) improved both their Mg and K mean levels, 3 (13%) improved Mg levels only and in 7 cases (30%), K levels alone rose.

CONCLUSIONS: Patient-reported and biochemical outcomes using modified-release Mg supplements were very favourable, and patient choice should play a large part in choosing Mg supplements with GS patients.

PMID 26940126  /  Robinson CM, Karet Frankl FE

Related Products
  • Magnesium Lactate Dihydrate EP Granular – Product Code 2531
  • Magnesium Lactate Dihydrate EP Low HM Granular – Product Code 2536
  • Magnesium Lactate Dihydrate EP Low HM Powder – Product Code 2533
  • Magnesium Lactate Dihydrate EP Powder – Product Code 2530
  • Magnesium Lactate Anhydrous Purified Powder – Product Code 2529
  • Magnesium Lactate Anhydrous Purified Granular – Product Code 2528
  • News
    • Company News
    • Product Development
    • Industry News
    • Awards
  • Events
  • Videos
  • Documents

Learn about new Jost products and events.
subscribe

  • Who We Are
  • Products
  • Documents
  • News
  • Contact
  • Careers
  • Spanish
  • German
  • French

Follow Us

  • linkedin
  • facebook

Jost Chemical Co.
(The Americas and Asia)
8150 Lackland
St. Louis, MO 63114
Tel: +1 314 428 4300
Fax: +1 314 428 4366
customer.service@jostchemical.comcustomer.service@jostchemical.com

Jost Chemical Europe SPRL
(Europe, Middle East and Africa)
Rue du Bois Portal 30/1-3
5300 Andenne, Belgium
Tel: +32 85 552 655
Fax: +32 85 552 654
customer.service@jostchemical.cominfo@josteurope.com

Sitemap     Privacy Policy     Cookies     Terms of Use

Copyright © 1995-2017 Jost Chemical Co. All rights reserved.